Lucienne Perceval
Family · Orlando, FLNPI 1184126427
Payments from drug & device makers
Across 62 payments — averaging $105.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$1K
- Viiv Healthcare Company$722
- Novo Nordisk$444
- Axsome Therapeutics, Inc.$360
- AstraZeneca$353
- Sanofi$331
- plus $3K from 24 others
What the payments were for
- Speaking & faculty fees$1002%
- Food & beverage$6,42998%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 9 | $1,069 |
| Viiv Healthcare Company | 7 | $722 |
| Novo Nordisk | 4 | $444 |
| Axsome Therapeutics, Inc. | 3 | $360 |
| AstraZeneca | 3 | $353 |
| Sanofi | 3 | $331 |
| Biogen | 3 | $302 |
| Grifols USA, LLC | 2 | $252 |
| Neurocrine Biosciences, Inc. | 2 | $250 |
| Idorsia Pharmaceuticals US Inc | 3 | $242 |
| Genentech USA, Inc. | 2 | $216 |
| AbbVie | 2 | $178 |
| Napo Pharmaceuticals Inc | 2 | $155 |
| Medtronic | 1 | $146 |
| Shield Therapeutics Inc | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Paratek Pharmaceuticals, Inc. | 1 | $116 |
| Eisai Inc. | 1 | $112 |
| Astellas Pharma US Inc | 1 | $112 |
| Abbott | 1 | $108 |
| Amgen | 1 | $101 |
| Medicure Pharma Inc. | 1 | $100 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| Abiomed | 1 | $96 |
| GSK | 1 | $92 |
| GRT US Holding, Inc. | 1 | $89 |
| Johnson & Johnson | 1 | $87 |
| Atricure, Inc. | 1 | $79 |
| Theratechnologies Inc. | 1 | $71 |
| Acella Pharmaceuticals, LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,551 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 19 | $15,215 |
| OzempicSemaglutide | 15 | $12,027 |
| Humulin 70-30Insulin Nph Hum/Reg Insulin Hm | 13 | $1,549 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $1,000 |
| Atorvastatin Calcium | 62 | $787 |
| Amlodipine Besylate | 62 | $434 |
| Gabapentin | 18 | $433 |
| Lisinopril | 52 | $311 |
| Hydralazine Hcl | 14 | $309 |
| Diclofenac Sodium | 16 | $190 |
| Metformin Hcl | 25 | $147 |
| Hydrochlorothiazide | 18 | $113 |
| Tamsulosin Hcl | 14 | $110 |
| Allopurinol | 12 | $107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $353 | $15,21519 claims |
| Novo NordiskOzempic | $444 | $12,02715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in Orlando
- Donna OrtizOrlando$417K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.